Vorinostat modulates the expression of the progesterone receptor in subtypes of triple-negative breast cancer cell lines

被引：0
|
作者：
Lyn-Cook, Beverly [1 ]
NouriEmamzadeh, Fatemeh [1 ]
Word, Beverly [1 ]
Moore, Rhonda [2 ]
Miranda-Carboni, Gustav [3 ]
机构：
[1] US FDA, Jefferson, AR USA
[2] US FDA, White Oak, MD USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2018年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B46
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [1] Subtypes of Triple-negative Breast Cancer Cell Lines React Differently to Eribulin Mesylate
    Braeutigam, Karen
    Mitzlaff, Katharina
    Uebel, Lisa
    Koester, Frank
    Polack, Stephan
    Pervan, Mascha
    Steinert, Gunnar
    Rody, Achim
    Liedtke, Cornelia
    ANTICANCER RESEARCH, 2016, 36 (06) : 2759 - 2766
  • [2] Androgen receptor expression in triple-negative breast cancer
    Glavynskyi, I.
    Dyatel, M.
    Zakhartseva, L.
    Guz, O.
    Zakhartsev, I.
    VIRCHOWS ARCHIV, 2017, 471 : S294 - S294
  • [3] Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
    Fink, Lauren S.
    Beatty, Alexander
    Devarajan, Karthik
    Peri, Suraj
    Peterson, Jeffrey R.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (01) : 298 - 306
  • [4] Classification of molecular subtypes of triple-negative breast cancer cell lines using two models
    Fernandez, Jose Rodrigo Espinosa
    Eckhardt, Bedrich L.
    Lee, Jangsoon
    Seitz, Robert S.
    Hout, David R.
    Ring, Brian Z.
    Lim, Bora
    Ueno, Naoto T.
    CANCER RESEARCH, 2018, 78 (04)
  • [5] Biological Subtypes of Triple-Negative Breast Cancer
    Hubalek, Michael
    Czech, Theresa
    Mueller, Hannes
    BREAST CARE, 2017, 12 (01) : 8 - 14
  • [6] MicroRNA expression in triple-negative versus other subtypes of breast cancer
    Kalniete, D.
    Nakazawa-Miklasevica, M.
    Strumfa, I.
    Abolins, A.
    Irmejs, A.
    Trofimovics, G.
    Gardovskis, J.
    Miklasevics, E.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S67 - S68
  • [7] Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines
    Crespo, Belen
    Illera, Juan Carlos
    Silvan, Gema
    Lopez-Plaza, Paula
    Herrera de la Muela, Maria
    de la Puente Yague, Miriam
    Diaz del Arco, Cristina
    Illera, Maria Jose
    Caceres, Sara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [8] Modulation of HDAC activity in subtypes of triple-negative breast cancer: Effects of vorinostat on HDAC 7 expression and cancer stem cells progression
    Emamzadeh, Fatemeh Nouri
    Hawkins, Anfernee
    Miranda-Carboni, Gustavo
    Moore, Rhonda
    Word, Beverly
    Lyn-Cook, Beverly
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [9] Directed Therapy of Subtypes of Triple-Negative Breast Cancer
    Carey, Lisa A.
    ONCOLOGIST, 2011, 16 : 71 - 78
  • [10] Developing therapies for triple-negative breast cancer subtypes
    Okines, Alicia
    Turner, Nicholas
    LANCET ONCOLOGY, 2024, 25 (02): : 149 - 151
12345